These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11173785)

  • 1. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
    Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
    Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
    Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
    Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations.
    Kar S; Chockalingam A
    Am J Ther; 2013 Jan; 20(1):57-60. PubMed ID: 21192242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
    Forcadell-Peris MJ; de Diego-Cabanes C
    Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyolysis complicated with acute renal insufficiency in a patient treated with gemfibrozil and cerivastatin].
    Vascónez Espinosa F; Gómez Rodríguez N; Martín Joven A; Posada García FJ
    Rev Clin Esp; 2001 Apr; 201(4):228-9. PubMed ID: 11447919
    [No Abstract]   [Full Text] [Related]  

  • 6. Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients.
    Unal A; Torun E; Sipahioglu MH; Tokgoz B; Kaya MG; Oymak O; Utas C
    Intern Med; 2008; 47(11):1017-9. PubMed ID: 18520113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-fibrate combination therapy.
    Shek A; Ferrill MJ
    Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal rhabdomyolysis caused by lipid-lowering therapy.
    Federman DG; Hussain F; Walters AB
    South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery time in a case of gemfibrozil and simvastatin-associated rhabdomyolysis.
    Cummins D; Mackey M; Baker E
    South Med J; 2009 Aug; 102(8):858-60. PubMed ID: 19593291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
    Graham DJ; Staffa JA; Shatin D; Andrade SE; Schech SD; La Grenade L; Gurwitz JH; Chan KA; Goodman MJ; Platt R
    JAMA; 2004 Dec; 292(21):2585-90. PubMed ID: 15572716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy.
    Pogson GW; Kindred LH; Carper BG
    Am J Cardiol; 1999 Apr; 83(7):1146. PubMed ID: 10190540
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.
    Dalugama C; Pathirage M; Kularatne SAM
    J Med Case Rep; 2018 May; 12(1):143. PubMed ID: 29784023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism.
    Kursat S; Alici T; Colak HB
    Clin Nephrol; 2005 Nov; 64(5):391-3. PubMed ID: 16312269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy.
    Marais GE; Larson KK
    Ann Intern Med; 1990 Feb; 112(3):228-30. PubMed ID: 2297197
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
    Watkins JL; Atkinson BJ; Pagliaro LC
    Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil.
    Alexandridis G; Pappas GA; Elisaf MS
    Am J Med; 2000 Aug; 109(3):261-2. PubMed ID: 11023440
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerivastatin and gemfibrozil-induced cardiac rhabdomyolysis.
    Su M; Hoffman RS; Flomenbaum M
    Am J Forensic Med Pathol; 2002 Sep; 23(3):305-6. PubMed ID: 12198364
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
    Ireland JH; Eggert CH; Arendt CJ; Williams AW
    Ann Intern Med; 2005 Jun; 142(11):949-50. PubMed ID: 15941707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.